Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses
Completed · Not applicable · NCT00748540
Conditions: Hearing Loss
At a glance
- Research payments reported, 2025
- $500
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 50
About the trial
- Sponsor
- Med-El Corporation
- Tested
- Vibrant Soundbridge (device)
- Dates
- Started 2007-12; completion 2014-03
- Results posted
- Yes
The purpose of this investigation is to collect feasibility data to assess the safety and efficacy of the Vibrant Soundbridge (VSB), a medical device designed to provide benefit in aided hearing thresholds, speech perception and sound quality to certain individuals with hearing loss with minimal changes in residual hearing. The VSB is currently indicated for adults with moderate-to-severe sensorineural hearing loss. Under the present investigation, adults with conductive and mixed hearing losses who are not successful users of traditional amplification will be assessed.
From ClinicalTrials.gov, last updated 2019-09-25. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Med-el Corporation reported $500 in research payments for this study in 2025 (1 payments).
Products named: Vibrating Ossicular Prosthesis (vorp 502b, Left), Vibrating Ossicular Prosthesis (vorp 502a, Right)
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Pittsburgh Ear Associates $500
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.